Evidence map›Paper›PMID 30949154›Full record

ArticleFrontiers in microbiology2019

Beatriz Del Rio, Esther Sánchez-Llana, Begoña Redruello, Alfonso H Magadan, María Fernández, Maria Cruz Martin, Victor Ladero, Miguel A Alvarez

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Enterococcal Phages: Food and Health Applications.Antibiotics (Basel, Switzerland) · 2023
    Review
  4. Viruses · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Characterization of the Bacteriophage vB_EfaS-271 InfectingInternational journal of molecular sciences · 2020
    Article
  10. Isolation and Characterization ofFrontiers in microbiology · 2020
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Beatriz Del RioDepartment of Biotechnology of Dairy Products, Institute of Dairy Products of Asturias - Spanish National Research Council (IPLA-CSIC), Villaviciosa, Spain.
Esther Sánchez-LlanaDepartment of Biotechnology of Dairy Products, Institute of Dairy Products of Asturias - Spanish National Research Council (IPLA-CSIC), Villaviciosa, Spain.
Begoña RedruelloDepartment of Biotechnology of Dairy Products, Institute of Dairy Products of Asturias - Spanish National Research Council (IPLA-CSIC), Villaviciosa, Spain.
Alfonso H MagadanLaboratoire Universitaire de Biodiversité et Ecologie Microbienne, Université de Bretagne Occidentale, Plouzané, France.
María FernándezDepartment of Biotechnology of Dairy Products, Institute of Dairy Products of Asturias - Spanish National Research Council (IPLA-CSIC), Villaviciosa, Spain.
Maria Cruz MartinDepartment of Biotechnology of Dairy Products, Institute of Dairy Products of Asturias - Spanish National Research Council (IPLA-CSIC), Villaviciosa, Spain.
Victor LaderoDepartment of Biotechnology of Dairy Products, Institute of Dairy Products of Asturias - Spanish National Research Council (IPLA-CSIC), Villaviciosa, Spain.
Miguel A AlvarezDepartment of Biotechnology of Dairy Products, Institute of Dairy Products of Asturias - Spanish National Research Council (IPLA-CSIC), Villaviciosa, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biogenic amines (BA) - nitrogenous compounds of low molecular weight - are the result of metabolism of certain amino acids. They are biologically present in all living organisms and play essential physiological roles. However, their accumulation in foodstuffs due to the metabolic activity of certain microorganisms represents a toxicological risk. Containing such microorganisms, and with an abundance of precursor substrate amino acids, fermented foods in general, and cheeses in particular, provide an ideal matrix for the accumulation of these toxic compounds. Unfortunately, the main microorganisms responsible for BA accumulation are members of the lactic acid bacteria (LAB) group, which are also essential for the development of the organoleptic characteristics of the final product. The methods used to reduce the BA content of cheese, such as milk pasteurization, commonly fail to do so, and affect desirable non-BA-producing LAB as well. Bacteriophages have been proposed as biotechnological tools for diminishing the presence of undesirable microorganisms in dairy products. Given their specificity, they could be used to target the population of BA-producing bacteria. In this work, we aimed to explore the use of

Indexed as

bacteriophagebiocontrolbiogenic aminesdairyEnterococcus faecalisputrescinetyramine

Identifiers

PMID30949154
PMCPMC6435515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.